Overview

Evaluating the Safety and Feasibility of TLD for the Treatment of Moderate to Severe Refractory Asthma

Status:
Not yet recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Prospective, multicenter, single-arm (non-randomized) study of Targeted Lung Denervation (TLD) Therapy in subjects with severe, refractory asthma.
Phase:
Phase 1
Details
Lead Sponsor:
Holaira
Treatments:
Glucocorticoids
Prednisone
Tiotropium Bromide